Overview

The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia

Status:
Completed

Trial end date:
2015-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the effects of Armodafinil, CBT-I, or the combination of the two on the sleep continuity of persons suffering from sleep disordered breathing and their adherence to CBT-I and Continuous Positive Airway Pressure (CPAP). Adults diagnosed with obstructive sleep apnea and who meet additional research and diagnostic criteria for insomnia will be recruited. Participants will submit daily sleep diaries and supplemental questionnaires as measures of study progress.

Phase:

N/A

Details

Lead Sponsor:

University of Pennsylvania

Collaborator:

Teva Pharmaceutical Industries, Ltd.

Treatments:

Armodafinil
Modafinil